Newly acquired ABS hits the acquisition trail as promised


Watson: Fosters is an excellent fit

Simpson Millar – the law firm acquired last month by AIM-listed Fairpoint Group – has begun making good on by snapping up Bristol-based family law firm Foster & Partners.

The alternative business structure, which already has a Bristol office, said it is seeking to establish itself as “the preeminent provider of family law services in Bristol and the South West”.

Founded in 1976, Fosters has nine lawyers and partner Paul Foster said “we have no doubt the nationwide reach, breadth of experience and resources that Simpson Millar brings will benefit all our clients”.

Emma Pearmaine, head of the family law department at Simpson Millar, said: “Family law is a key area of growth for Simpson Millar so combining our nationwide practice groups with Fosters makes for a formidable partnership that will help establish a strong footprint in the region and deliver even more comprehensive legal solutions to clients.”

Managing director Peter Watson added: “Fosters is an excellent fit for our business and we are delighted that they have agreed to join with us. We have developed a very positive reputation in the legal sector for the manner in which we have conducted our consolidation activities and in step with our stated strategy as part of Fairpoint Group PLC, we will be pursuing further strategic acquisitions in the near future.”




Blog


Regulation, growth and access to justice: why legal services need a reset

Well-intentioned consumer protections embedded in the regulation of legal services increasingly act as barriers to innovation, competition and access to justice.


Digital marketing for law firms in 2026 – where to focus your efforts

Digital marketing for law firms in 2026 is more demanding than ever. AI is reshaping content, while audiences are becoming more selective and platforms are raising the bar on quality.


Doug Hargrove

From AI ambition to operational reality

AI is no longer an emerging technology on the horizon. It has become the connective tissue binding law, regulation, risk and commercial decision-making.


Loading animation